Comparison of Visual Outcomes After Implantation of the POD AY GF F (PhysIOL) and the POD AY 26P F (PhysIOL)
NCT ID: NCT02981186
Last Updated: 2021-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2016-11-02
2017-09-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To decide which eye receives POD F and which eye receives POD F GF, a randomization table will be provided to the principle investigator.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Visual Outcomes After Implantation of the POD FT and the POD F
NCT04943809
Comparison of Clinical Outcomes POD L GF vs POD F GF (PHY1707)
NCT03688399
Comparison of Viusal Outcomes After Implantation of the POD 26% FineVision Toric (PhysIOL) and POD 26% Toric (PhysIOL)
NCT02426385
Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes
NCT04699266
Comparison of Clinical Outcomes on Trifocal IOLs FineVision POD F GF and FineVision POD F in Asian Eyes
NCT03306355
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Follow up will be up to 6 months postoperative.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IOL Implantation experimental
Implantation of POD F GF in one of the eyes of the study subject
IOL implantation experimental
Implantation of trifocal IOL POD F GF consisting of hydrophobic material
IOL Implantation Comparator
Implantation of POD F in the contralateral eye of the study subject
IOL implantation comparator
Implantation of trifocal IOL POD F consisting of hydrophilic material
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IOL implantation experimental
Implantation of trifocal IOL POD F GF consisting of hydrophobic material
IOL implantation comparator
Implantation of trifocal IOL POD F consisting of hydrophilic material
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient older than 50 years old
* Regular corneal astigmatism \<0.75 dioptres by an automatic keratometer (regularity determined by the topography of the keratometry) or \<1.0 dioptres if the steep axis of cylinder is between 90° and 120°
* Spontaneously emitting the desire for spectacle independence after surgery and with realistic expectation.
* Availability, willingness and sufficient cognitive awareness to comply with examination procedures
* Signed informed consent
Exclusion Criteria
* Irregular astigmatism
* Difficulty for cooperation (distance from their home, general health condition)
* Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)
* Any ocular comorbidity
* History of ocular trauma or prior ocular surgery including refractive procedures
* Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome)
* Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beaver-Visitec International, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zoltan Nagy, MD
Role: PRINCIPAL_INVESTIGATOR
Semmelweis University - Department of Ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Semmelweis University - Department of Ophthalmology
Budapest, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHY1603
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.